Internal Medicine, Cardiovascular Disease · Great Neck, NY
NPI
1457397861
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
225 Community Dr, Suite 130
Great Neck, NY, 11021
Phone (516) 504-0474
Groups this clinician bills Medicare through
Medicare paid, 2024
$319K
4,954 services
Medicare patients, 2024
952
Average age 76
Drug cost, 2024
$1.3M
5,615 prescriptions
Company payments, 2025
$28.8
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jay J Lisker was code 93000 (electrocardiogram), 1,361 times for 784 patients. In total Jay J Lisker billed 4,954 services in 42 codes, and Medicare paid $319K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 1,361 | 784 | $12.38 | $17K |
| 99214 Office E&M - Established | Office | 1,093 | 633 | $111.01 | $121K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 637 | 422 | $14.50 | $9,240 |
| 93306 Echocardiography (TTE/TEE) | Office | 328 | 316 | $178.53 | $59K |
| 99215 Office E&M - Established | Office | 171 | 142 | $164.38 | $28K |
| 99204 Office E&M - New | Office | 113 | 113 | $141.28 | $16K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 112 | 28 | $6.06 | $679 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 105 | 54 | $100.80 | $11K |
| 93015 Electrocardiogram | Office | 88 | 88 | $51.99 | $4,575 |
| 99213 Office E&M - Established | Office | 66 | 62 | $79.63 | $5,255 |
| 93351 Echocardiography (TTE/TEE) | Office | 60 | 60 | $206.25 | $12K |
| 78452 Myocardial Perfusion Scan | Office | 51 | 51 | $403.30 | $21K |
| 93244 Electrocardiogram | Office | 37 | 37 | $19.80 | $732 |
| 93242 Electrocardiogram | Office | 35 | 35 | $11.13 | $390 |
| 99203 Office E&M - New | Office | 21 | 21 | $92.03 | $1,933 |
By year: 2022 $332K for 3,694 services; 2023 $299K for 3,645 services; 2024 $319K for 4,954 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 16 | 16 | $2.98 | $47.67 |
Medicare prescription drug claims, 2024
In 2024, the drug Jay J Lisker prescribed most often to Medicare patients was Metoprolol Succinate, with 832 prescriptions and refills. In total Jay J Lisker wrote 5,615 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 832 | 2,363 | 258 | $15K |
| Atorvastatin Calcium Generic | 663 | 1,898 | 229 | $7,723 |
| Rosuvastatin Calcium Generic | 482 | 1,413 | 153 | $7,180 |
| Amlodipine Besylate Generic | 425 | 1,191 | 142 | $3,147 |
| Eliquis Apixaban | 289 | 566 | 77 | $326K |
| Valsartan Generic | 223 | 504 | 62 | $5,056 |
| Carvedilol Generic | 187 | 485 | 53 | $1,975 |
| Xarelto Rivaroxaban | 186 | 377 | 43 | $205K |
| Losartan Potassium Generic | 172 | 503 | 57 | $1,655 |
| Clopidogrel Clopidogrel Bisulfate | 166 | 438 | 51 | $2,127 |
| Hydrochlorothiazide Generic | 150 | 354 | 49 | $740 |
| Entresto Sacubitril/Valsartan | 143 | 305 | 40 | $202K |
| Ezetimibe Generic | 121 | 346 | 44 | $3,392 |
| Spironolactone Generic | 101 | 241 | 36 | $656 |
| Repatha Sureclick Evolocumab | 93 | 112 | 15 | $57K |
Brand drugs: 931 claims; generic drugs: 4,684 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jay J Lisker $28.8 ($28.8 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $28.8.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $28.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.